Hot Features
Premium
Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Período:
Tipo de Línea:
| Volume | 1,000 |
|
|||||
| Noticias | - |
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Estrella Immunopharma Inc | ESLAW | NASDAQ | Warrant Capital Accionario |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.091 | 09:07:20 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 0.0899 | 0.0899 | 0.091 | 0.091 |
| Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio |
|---|---|---|---|---|
| 7 | 1,000 | 0.0902 | 90 | - |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 09:07:20 | 600 | 0.091 | USD |
Información Financiera Estrella Immunopharma Inc ESLAW
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 3.31M | 36.38M | - | 0 | -7.31M | -0.20 | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre Estrella Immunopharma Inc ESLAW
| Fecha | Hora | Fuente | Noticia |
|---|---|---|---|
| 27/11/2024 | 07:45 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 26/11/2024 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 25/11/2024 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 18/11/2024 | 16:18 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 14/11/2024 | 15:15 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 07/11/2024 | 16:27 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
| 07/11/2024 | 16:26 | Edgar (US Regulatory) | Form 8-K - Current report |
| 28/10/2024 | 16:03 | Edgar (US Regulatory) | Form 10-K/A - Annual report [Section 13 and 15(d), not S-K.. |
| 02/10/2024 | 16:19 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 27/9/2024 | 11:00 | Business Wire | Estrella Immunopharma Achieves Complete Response in First.. |
| 14/8/2024 | 11:00 | Business Wire | Estrella Immunopharma Announces Appointment of Hong Zhang as.. |
Histórico ESLAW
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
